Quansys Biosciences, a leader in multiplex immunoassay technology, today announced the launch of the Q-View™ Imager Plus, a next-generation imaging device designed to deliver reproducible, high-resolution ELISA results with streamlined workflows. Paired with the newly upgraded Q-View™ Software, the platform combines advanced imaging hardware with powerful and user-friendly analysis tools built to help academic, biopharma, and clinical laboratories generate reliable, publication quality, and regulation-ready data with speed and confidence.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250729506754/en/

The new Q-View™ Imager Plus and its upgraded Q-View™ Software, when used together to analyze Q-Plex Multiplex ELISA test kits, provide consistent, high-quality data, for use in academic, biopharma, and clinical laboratories.

At the core of the Q-View™ Imager Plus is a 35-megapixel multi-camera system with temperature-controlled sensors, offering high resolution images and consistent data quality across every plate. This design ensures reliable performance for both research and regulated laboratory environments, making it one of the most advanced imaging solutions in its class.

“We designed the Q-View™ Imager Plus and its upgraded Q-View™ Software to provide labs with consistent, high-quality data,” said Adam Brown, CEO at Quansys Biosciences. “By combining advanced imaging with power and intuitive analysis tools, we have been able to deliver on our commitment to empower labs with tools that simplify complex workflows and deliver high-impact results, faster.”

While most plate readers merely scan data points, the Q-View™ Imager Plus captures crystal-clear photographic images of 96-well plates and processes them in real time, allowing scientists to extract more meaningful results with less variability. The improved system extracts richer data with confidence, with active cooling ensuring consistent data from one image to the next, which is an essential requirement for clinical and regulatory settings.

Key features include:

• Pre-focused optics for plug-and-play performance
• Integrated barcode scanning for automatic plate identification and reduced user error
• Internal qualification lighting for precise calibration without the need for external powered devices
• Durable and compact design, ideal for crowded lab environments
• Energy-saving mode to minimize wear, energy use, and noise when idle
• Compatible with automation and liquid handlers for high-throughput labs
• Field-upgradable firmware ensures longevity and adaptability

“Our goal with the Q-View Imager Plus was to give scientists a tool that combines high-quality imaging with practical usability,” said Dr. Kyle Berg PhD, who leads the R&D team at Quansys Biosciences. “Every feature, from the pre-focuses optics to the integrated software, was engineered to reduce variability and make multiplex ELISA workflows faster and more reliable.”

Availability

The Q-View™ Imager Plus is now available for purchase worldwide. To request pricing or more information, visit www.quansysbio.com/q-view-imager-plus, or contact sales@quansysbio.com.

About Quansys Biosciences

Quansys Biosciences is a leading biotechnology company specializing in multiplex ELISA testing solutions and quantitative protein analysis for both research and clinical applications. Its Q-Plex™ product line, Q-View™ Software, and Q-View™ Imagers are trusted by scientists and clinicians around the world to study a wide range of diseases, including infectious diseases, cancer, and autoimmune disorders. By delivering tools that improve efficiency, accuracy, and insight, Quansys empowers laboratories to generate high-quality biomarker data with confidence.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250729506754/en/

The new Q-View Imager Plus, along with the updated Q-View Software, provide consistent, high-quality data, for use in academic, biopharma, and clinical laboratories.